methotrexate has been researched along with E coli Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowden, K; Harris, NV; Smith, C | 1 |
| Costescu-Green, D; Gerster, KM; Persadie, RJ | 1 |
| Badgwell, B; Carson, WE; Dierksheide, J; Magro, C; Parihar, R; Russo, T | 1 |
| Aringer, M; Graninger, WB; Smolen, JS; Steiner, G | 1 |
| Albert, A; Cazenave, JP; Javier, RM; Kuntz, JL; Sibilia, J | 1 |
| Harding, B; MacLennan, IC | 1 |
| Jamieson, PA; Price, RA | 1 |
7 other study(ies) available for methotrexate and E coli Infections
| Article | Year |
|---|---|
Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines.
Topics: Animals; Anti-Bacterial Agents; Cattle; Chemical Phenomena; Chemistry; Escherichia coli; Escherichia coli Infections; Folic Acid Antagonists; Liver; Mice; Molecular Structure; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 1990 |
Cervical Ectopic Pregnancy Complicated by Escherichia Coli Septicemia: A Case Report.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Cervix Uteri; Escherichia coli Infections; Female; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy, Ectopic; Sepsis | 2016 |
Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; Cells, Cultured; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Endothelium, Vascular; Escherichia coli Infections; Etoposide; Female; Humans; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Killer Cells, Natural; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; NF-kappa B; Phosphorylation; Receptors, Antigen, T-Cell; Sepsis; Spleen; STAT1 Transcription Factor; Survival Rate; Trans-Activators; Tumor Necrosis Factor-alpha; Umbilical Veins | 2002 |
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Autoantibodies; Azathioprine; Bacteremia; Cardiolipins; Complement System Proteins; DNA; Escherichia coli Infections; Female; Humans; Immunosuppressive Agents; Infliximab; Lupus Erythematosus, Systemic; Lupus Nephritis; Methotrexate; Middle Aged; Safety; Treatment Outcome; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 2004 |
Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bacteremia; Bone Marrow Cells; Escherichia coli Infections; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Macrophages; Methotrexate; Middle Aged; Pancytopenia; Sulfasalazine | 1998 |
Myelotoxicity of methotrexate in animals with pyogenic infection.
Topics: Agranulocytosis; Animals; Escherichia coli Infections; Female; Hydronephrosis; Leukocyte Count; Methotrexate; Neutropenia; Rats; Time Factors | 1977 |
The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy.
Topics: Adolescent; Age Factors; Autopsy; Brain; Brain Neoplasms; Child; Child, Preschool; Escherichia coli Infections; Female; Humans; Infant; Injections, Intravenous; Leukemia, Lymphoid; Leukoencephalopathy, Progressive Multifocal; Male; Methotrexate; Nutrition Disorders; Radiotherapy; Radiotherapy Dosage | 1975 |